From denied claim to appeal letter in under 60 seconds

Every step is designed to save you time and maximize overturn rates. Here's exactly how Swivel works.

Step 1

Pattern Recognition Built In

Enter the denial code, payer, and procedure — or snap a photo of the denial with your phone to upload automatically. Our system instantly recognizes the pattern and begins building your appeal strategy. Works across all major payers and specialties.

Senial Code CO-50
Payer Aetna
Specialty Oncology
Procedure Pembrolizumab
Pattern matched: 73% overturn rate for CO-50 + Aetna + Oncology
Step 2

We Tell You Exactly What to Pull

No guessing what documentation to include. Our system generates a ranked checklist based on the specific denial code and payer — with critical items flagged first.

PD-L1 expression results Critical
Tumor staging documentation Critical
Prior therapy history Important
Pathology report Important
Treatment rationale note Supporting
Payer insight: Aetna requires PD-L1 >= 1% for first-line approval
Step 3

From Shorthand to Structured Prose

Paste your clinical notes as-is — abbreviations, shorthand, all of it. Our system transforms them into compelling, structured medical narrative that payers take seriously.

Your Input

pt w/ stage IIIB NSCLC, PD-L1 80%, failed carbo/pem, now prog on doce. Pembro appropriate per NCCN. Med nec clearly established.

Swivel Output

The patient presents with Stage IIIB non-small cell lung cancer (NSCLC) with a PD-L1 tumor proportion score of 80%. Following disease progression on first-line carboplatin/pemetrexed and subsequent docetaxel therapy, pembrolizumab represents the evidence-based standard of care per NCCN Clinical Practice Guidelines v.2.2024...

Step 4

Ready to Print and Send

A complete, formatted appeal letter citing the specific payer policy, clinical guidelines, and peer-reviewed evidence. Includes overturn rate data and deadline tracking.

APPEAL LETTER — GENERATED
Re: Appeal of Denied Claim — CO-50
Aetna Medical Director | Pembrolizumab

Dear Medical Director,

I am writing to formally appeal the denial of coverage for pembrolizumab (Keytruda) under denial code CO-50 for our patient...

[ Full letter continues — 2-3 pages ]

73% overturn rate
Deadline: 147 days

Ready To Try It Yourself?

Get a free appeal letter — cancel anytime. See what Swivel can do for your practice.